These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6330491)

  • 21. Diphtheria-tetanus-pertussis vaccine shortage.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1985 Feb; 34(7):103-4. PubMed ID: 3918248
    [No Abstract]   [Full Text] [Related]  

  • 22. [Immunization of children with long-term diarrhea].
    Sal'nikova SI; Aleksina SG
    Pediatriia; 1991; (9):66-8. PubMed ID: 1754353
    [No Abstract]   [Full Text] [Related]  

  • 23. Why children are not immunised.
    Hull D
    J R Coll Physicians Lond; 1987 Jan; 21(1):28-31. PubMed ID: 3493341
    [No Abstract]   [Full Text] [Related]  

  • 24. Antibody response to measles vaccine with DTPP.
    John TJ; Selvakumar R; Balrai V; Simoes EA
    Am J Dis Child; 1987 Jan; 141(1):14. PubMed ID: 3491536
    [No Abstract]   [Full Text] [Related]  

  • 25. Can injection technique reduce vaccine reactions?
    Harris G
    Practitioner; 1983 Feb; 227(1376):299-300. PubMed ID: 6602979
    [No Abstract]   [Full Text] [Related]  

  • 26. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.
    Grimprel E; von Sonnenburg F; Sänger R; Abitbol V; Wolter JM; Schuerman LM
    Vaccine; 2005 May; 23(28):3657-67. PubMed ID: 15882526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progress in worldwide control and elimination of disease through immunization.
    Hayden GF; Sato PA; Wright PF; Henderson RH
    J Pediatr; 1989 Apr; 114(4 Pt 1):520-7. PubMed ID: 2647942
    [No Abstract]   [Full Text] [Related]  

  • 28. Why wait for DTP-E-IPV?
    Marcuse EK
    Am J Dis Child; 1989 Sep; 143(9):1006-7. PubMed ID: 2788991
    [No Abstract]   [Full Text] [Related]  

  • 29. [Poliomyelitis, tetanus and diphtheria. May anamnesis show the need for increased number of vaccinations?].
    Runehagen A
    Lakartidningen; 1994 Nov; 91(47):4350, 4355-6. PubMed ID: 7808139
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical trial of concentrated inactivated polio vaccine in a simplified immunization program.
    Fillastre C; Emmou C; Meyran M; Schlumberger M; Guérin N
    Dev Biol Stand; 1981; 47():207-13. PubMed ID: 6262148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Whooping cough--not eradicated, but forgotten].
    Swidsinski S; Schlesinger FL; Mebel S
    Z Arztl Fortbild (Jena); 1989; 83(6):309-12. PubMed ID: 2660433
    [No Abstract]   [Full Text] [Related]  

  • 32. Human peripheral blood lymphocytes from recently vaccinated individuals produce both type-specific and intertypic cross-reacting neutralizing antibody on in vitro stimulation with one type of poliovirus.
    Uytdehaag FG; Loggen HG; Logtenberg T; Lichtveld RA; van Steenis B; van Asten JA; Osterhaus AD
    J Immunol; 1985 Nov; 135(5):3094-101. PubMed ID: 2931478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccination rates in a multicultural population.
    van der Wal MF; Diepenmaat AC; Pel JM; Hirasing RA
    Arch Dis Child; 2005 Jan; 90(1):36-40. PubMed ID: 15613508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Injections and poliomyelitis: what are the risks of vaccine associated paralysis?
    Wyatt HV
    Dev Biol Stand; 1986; 65():123-6. PubMed ID: 3549394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The efficacy of DPT and oral poliomyelitis immunization schedules initiated from birth to 12 weeks of age.
    Halsey N; Galazka A
    Bull World Health Organ; 1985; 63(6):1151-69. PubMed ID: 3914926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [With new strategies against vaccination gaps in adulthood].
    MMW Fortschr Med; 2007 Aug; 149(31-32):17. PubMed ID: 17849780
    [No Abstract]   [Full Text] [Related]  

  • 37. Panel on immunizations.
    Fulginiti VA; Nelson JD; McCracken GH
    Pediatr Infect Dis; 1983; 2(3 Suppl):S64-9. PubMed ID: 6866802
    [No Abstract]   [Full Text] [Related]  

  • 38. Safety, reactogenicity and immunogenicity of a combined hexavalent tetanus, diphtheria, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate vaccine, for primary immunization of infants.
    Zepp F; Knuf M; Heininger U; Jahn K; Collard A; Habermehl P; Schuerman L; Sänger R
    Vaccine; 2004 Jun; 22(17-18):2226-33. PubMed ID: 15149781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simultaneous administration of hepatitis B and diphtheria/tetanus/polio vaccines.
    Chiron JP; Coursaget P; Yvonnet B; Auger F; Lee Quan T; Barin F; Denis F; Diop-Mar I
    Lancet; 1984 Mar; 1(8377):623-4. PubMed ID: 6142323
    [No Abstract]   [Full Text] [Related]  

  • 40. An adolescent-adult formulation tetanus and diptheria toxoids adsorbed combined with acellular pertussis vaccine has comparable immunogenicity but less reactogenicity in children 4-6 years of age than a pediatric formulation acellular pertussis vaccine and diphtheria and tetanus toxoids adsorbed combined with inactivated poliomyelitis vaccine.
    Langley JM; Predy G; Guasparini R; Law B; Diaz-Mitoma F; Whitstitt P; Tapiero B; Dionne M; Tomovici A; Mills E; Halperin SA
    Vaccine; 2007 Jan; 25(6):1121-5. PubMed ID: 17045366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.